Gland Pharma Limited
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model…
What Gland files
- Others76
- Investor Meet74
- Important27
- Updates23
- Board Meeting11
- PPTs6
Gland Pharma Limited has scheduled one-on-one and group meetings with institutional investors and analysts, including East Bridge Capital, IIFL Capital, Antique Broking, and a group session arranged by Nomura, to discuss company operations and business updates.
Gland Pharma Limited has announced a one-on-one meeting scheduled with DSP Mutual Fund to discuss general business updates and company operations.
Gland Pharma Limited has scheduled a one-on-one meeting with Kotak Mutual Fund on September 09, 2026, as part of its analyst/institutional investor engagement.
Gland Pharma's VSEZ Sterile Oncology Formulations & API Facilities in Visakhapatnam successfully cleared a USFDA Good Manufacturing Practice (GMP) inspection, concluding with zero (0) Form 483 observations. This is a positive operational development.
Gland Pharma Limited has scheduled one-on-one and group meetings with various institutional investors and analysts. Participants include Carnelian Capital, First Ray Capital, WCM Investment, LIC MF, ICICI Securities, BofA Securities, and JP Morgan.